BioCentury
ARTICLE | Company News

Allon, Paladin deal

July 22, 2013 7:00 AM UTC

Paladin completed its acquisition of neurology company Allon for C$1 ($0.96) for all outstanding Allon shares, plus C$900,000 ($866,637) in cash. Paladin said Allon will be a Paladin subsidiary for a ...